Cargando…
Endotyping of Cholesteatoma: Which Molecular Biomarkers? A Systematic Review
Background: So far, no medical treatment is available for cholesteatoma (C) and the only effective therapy is complete surgical removal, but recurrence is common even after surgical treatment. While C is classically divided into two clinical phenotypes, congenital and acquired, only a few studies ha...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409631/ https://www.ncbi.nlm.nih.gov/pubmed/36013295 http://dx.doi.org/10.3390/jpm12081347 |